| Identification | Back Directory | [Name]
Edrecolomab | [CAS]
156586-89-9 | [Synonyms]
17-1A
Panorex
Edrecolomab
Immunoglobulin G 2A (mouse monoclonal 17-1A gamma-chain anti-human colon canceer tumor-associated antigen), disulfide with mouse monoclonal 17-1A light chain, dimer
Immunoglobulin G2A, anti-(human colon cancer tumor-associated antigen) (mouse monoclonal 17-1A gamma2A-chain), disulfide with mouse monoclonal 17-1A light chain, dimer | [MDL Number]
MFCD09832780 |
| Hazard Information | Back Directory | [Uses]
Monoclonal antibody (antineoplastic adjuvant). | [Brand name]
Panorex (Centocor). | [in vivo]
Edrecolomab (intravenous injection; 30 μg/dose; day 1, 4 and 7 after tumor-cell inoculation) treatment inhibits tumor growth in the HT-29 nude mouse model[1]. | Animal Model: | Male nu/nu mice injected with HT-29 colon carcinoma cells[1] | | Dosage: | 30 μg/dose | | Administration: | Intravenous injection; 30 μg/dose; day 1, 4 and 7 after tumor-cell inoculation | | Result: | Inhibited tumor growth with a number of significant readings (p≤0.05). |
|
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|